FDA — authorised 17 December 2009
- Application: ANDA090574
- Marketing authorisation holder: PHARMOBEDIENT
- Local brand name: COSYNTROPIN
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Adrenocorticotropin in United States
FDA authorised Adrenocorticotropin on 17 December 2009
Marketing authorisation
Other Other approved in United States
Frequently asked questions
Is Adrenocorticotropin approved in United States?
Yes. FDA authorised it on 17 December 2009.
Who is the marketing authorisation holder for Adrenocorticotropin in United States?
PHARMOBEDIENT holds the US marketing authorisation.